Integer Holdings Co. (NYSE:ITGR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Integer Holdings Co. (NYSE:ITGR) have been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $138.71.

A number of research analysts recently weighed in on the stock. Truist Financial raised their target price on shares of Integer from $145.00 to $150.00 and gave the company a “buy” rating in a research report on Monday, October 14th. Oppenheimer assumed coverage on Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price objective for the company. Bank of America upped their target price on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. KeyCorp raised their price target on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Finally, Benchmark reiterated a “buy” rating and set a $130.00 price objective on shares of Integer in a research note on Wednesday, October 2nd.

Insiders Place Their Bets

In other news, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares of the company’s stock, valued at $272,824.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 2.00% of the company’s stock.

Institutional Trading of Integer

Hedge funds have recently modified their holdings of the stock. Contravisory Investment Management Inc. raised its holdings in Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 80 shares during the period. Quest Partners LLC lifted its holdings in Integer by 3,688.9% during the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 332 shares during the last quarter. GAMMA Investing LLC boosted its stake in Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after purchasing an additional 142 shares during the period. Headlands Technologies LLC acquired a new position in Integer in the 1st quarter valued at $106,000. Finally, Innealta Capital LLC bought a new position in Integer during the 2nd quarter worth $110,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

Shares of Integer stock opened at $130.43 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of 45.13, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. Integer has a one year low of $69.40 and a one year high of $133.53. The stock’s 50-day moving average is $126.80 and its 200-day moving average is $120.63.

Integer (NYSE:ITGR) last released its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating the consensus estimate of $1.24 by $0.06. The firm had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 EPS. Equities analysts predict that Integer will post 5.3 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.